Multimorbidity is challenging for both patients and healthcare systems due to its increasing
prevalence and high impact on people's health and well-being. The risk of multimorbidity …

Background Meaningful engagement with stakeholders in the provision of healthcare and
services is recommended by the World Health Organisation. Culturally specific evaluation …

Chronic obstructive pulmonary disease (COPD) is a heterogeneous group of chronic lung
conditions. Genome-wide association studies have identified single-nucleotide …

Eczema and asthma are allergic diseases and two of the commonest chronic conditions in
high-income countries. Their co-existence with other allergic conditions is common, but little …

The current availability of electronic health records represents an excellent research
opportunity on multimorbidity, one of the most relevant public health problems nowadays …

Various comorbidities and multimorbidity frequently occur in chronic obstructive pulmonary
disease (COPD), leading to the overload of health care systems and increased mortality. We …

A major risk factor of COVID-19 severity is the patient's health status at the time of the
infection. Numerous studies focused on specific chronic diseases and identified conditions …

Multimorbidity is known to impair Quality of Life (QoL) in patients in a primary setting. Poor
QoL is associated with higher dyspnea perception. How multimorbidity and dyspnea …

Introduction The presence of multiple chronic conditions, also referred to as multimorbidity,
is a common finding in adults. Epidemiologic research can help identify groups of …

Study Objectives: Chronic noncancer pain (CP) commonly co-occurs with obstructive sleep
apnea (OSA) and may contribute to greater symptom burden. The study aims were to (1) …